Introduction
For international patients considering cancer treatment or a second opinion in Shanghai, two institutions frequently come up in the same conversation: Gobroad Medical Group and Fudan University Shanghai Cancer Center (FUSCC). They represent two distinct models of oncology care — one built around international patient experience and private-sector agility, the other around the depth of a dedicated public cancer specialty hospital with one of the highest case volumes in Asia.
Neither is universally "better." The right choice depends on your diagnosis, your priorities, your budget, and the kind of care experience you are looking for. This guide offers an objective comparison to help you think through the decision — and explains how China Medical Concierge Shanghai (CMCS) can coordinate access to both.
Section 1 — Gobroad Medical Group (广博医疗)
About Gobroad
Gobroad is a private international medical group with a dedicated focus on oncology. Operating across multiple cities in China including Shanghai and Beijing, Gobroad has built its model around serving international patients and Chinese patients seeking a premium, internationally oriented care experience. Its facilities are designed with international standards in mind, and its patient coordination infrastructure is among the most developed in China's private oncology sector.
Gobroad works with a range of international health insurance providers and offers direct billing arrangements that can simplify the financial process for patients with overseas coverage.
Core Strengths
- International patient experience: English-speaking medical and coordination teams, streamlined intake processes, and a service model designed for patients arriving from abroad
- Speed of access: Appointments can typically be arranged within days, without the waiting periods that can occur at high-volume public hospitals
- Multidisciplinary consultation: MDT case review services are available for complex cases
- Insurance compatibility: Established relationships with international health insurers, including direct billing for eligible patients
- Integrated coordination: Visa guidance, accommodation support, and in-hospital logistics are part of the service offering
- Advanced treatment modalities: Access to proton therapy and other advanced treatment technologies at select centers
Who Is Gobroad Best Suited For?
- International patients who require a fully English-language care environment
- Patients with international health insurance seeking direct billing
- Patients who need to begin treatment quickly and value a streamlined private-sector experience
- Patients seeking a premium service environment alongside clinical care
Oncology Focus Areas
Gobroad's oncology programs cover a broad range of cancer types, with particular capacity in lung cancer, breast cancer, gastrointestinal cancers, and hematological malignancies. Its multidisciplinary teams bring together medical oncologists, surgical oncologists, and radiation oncologists for integrated case management.
Section 2 — Fudan University Shanghai Cancer Center (FUSCC 复旦大学附属肿瘤医院)
About FUSCC
Founded in 1931, Fudan University Shanghai Cancer Center is one of China's oldest and most established dedicated cancer hospitals. As a public institution affiliated with Fudan University, FUSCC is both a clinical center and a major research institution — designated as a National Cancer Clinical Medical Research Center by the Chinese government. Its entire clinical infrastructure is focused exclusively on oncology, which means every resource, every specialist, and every protocol is oriented toward cancer care.
FUSCC handles one of the highest volumes of cancer cases in China annually, which translates into deep accumulated experience across both common and rare tumor types.
Core Strengths
- Exclusive oncology focus: 100% of FUSCC's clinical activity is cancer-related. There are no competing priorities from other medical specialties.
- Case volume and experience: Among the highest cancer case volumes in China, providing genuine depth of experience even for uncommon tumor types
- Clinical research and trials: FUSCC participates in a large number of domestic and international clinical trials, giving eligible patients access to investigational therapies not yet widely available
- Radiation oncology: One of China's leading radiation therapy centers, with advanced capabilities including proton and heavy-ion therapy
- Breast cancer program: One of Asia's largest and most experienced breast cancer centers, with particular expertise in breast-conserving surgery, sentinel lymph node techniques, and complex reconstructive cases
- Head and neck oncology: A nationally recognized program for head and neck cancers, including thyroid, nasopharyngeal, and oral cavity tumors
- Gynecological oncology: Strong dedicated program for cervical, ovarian, and endometrial cancers
Who Is FUSCC Best Suited For?
- Patients with breast cancer, head and neck cancer, gynecological cancers, or thoracic malignancies seeking the deepest available specialist experience
- Patients who wish to explore clinical trial eligibility for innovative therapies
- Patients with complex or rare tumor types who benefit from high case-volume specialist experience
- Patients for whom treatment cost is a significant consideration (public hospital pricing)
Key Specialists at FUSCC
Prof. Shao Zhimin (邵志敏) — Director of the Breast Cancer Center at FUSCC and one of China's foremost authorities on breast cancer. Prof. Shao has led the development of FUSCC's breast cancer program into one of Asia's largest, with particular expertise in the surgical and systemic management of complex breast cancer cases, including triple-negative breast cancer and locally advanced disease.
Prof. Wu Jiong (吴炵) — A leading breast surgical oncologist at FUSCC, recognized for his expertise in breast-conserving surgery, oncoplastic techniques, and the multidisciplinary management of early and locally advanced breast cancer. Prof. Wu has contributed significantly to the development of breast cancer surgical standards in China.
Prof. Zhang Zhen (章真) — Director of the Department of Radiation Oncology at FUSCC. Prof. Zhang is one of China's leading radiation oncologists, with extensive experience in the treatment of gastrointestinal cancers, rectal cancer, and other solid tumors requiring precision radiotherapy. Her department is among the most technically advanced radiation oncology programs in China.
Prof. Ye Dingwei (叶定威) — A leading urological oncologist at FUSCC, with particular expertise in prostate cancer, bladder cancer, and kidney cancer. Prof. Ye is recognized for his work in minimally invasive urological oncology surgery and the multidisciplinary management of genitourinary malignancies.
Section 3 — Side-by-Side Comparison
| Factor | Gobroad | FUSCC |
|---|---|---|
| Institution type | Private international medical group | Public cancer specialty hospital |
| Primary language | English available throughout | Chinese (CMCS provides full coordination) |
| Appointment speed | Very fast (1–3 days) | Fast via CMCS (3–7 days) |
| Pricing | Private sector rates | Public hospital rates |
| International insurance | Widely accepted, direct billing available | Selective; CMCS can advise |
| Annual case volume | Moderate | Very high |
| Clinical trial access | Limited | Extensive |
| Radiation / proton therapy | Available at select centers | Top-tier program including proton/heavy-ion |
| Breast cancer | Competent program | One of Asia's largest dedicated centers |
| Head and neck cancer | Available | Nationally recognized program |
| International patient experience | Designed for international patients | Requires CMCS coordination for international patients |
| MDT availability | Yes | Yes (regular structured MDT) |
Section 4 — Choosing by Diagnosis
| Diagnosis | Recommended | Rationale |
|---|---|---|
| Breast cancer | FUSCC | One of Asia's largest and most experienced breast cancer centers |
| Head and neck cancer | FUSCC | Nationally recognized dedicated program |
| Gynecological oncology | FUSCC | Strong dedicated program with high case volume |
| Radiation therapy (complex) | FUSCC | Top-tier radiation oncology including proton/heavy-ion |
| Clinical trial eligibility | FUSCC | Extensive trial portfolio across tumor types |
| Lung cancer | Either, case-dependent | Both have capable programs; CMCS will advise based on staging and treatment needs |
| Gastrointestinal cancers | Either, case-dependent | FUSCC for radiation-heavy protocols; Gobroad for international service preference |
| Full English service required | Gobroad | Designed for international patients without language support |
| International insurance / direct billing | Gobroad | Established insurer relationships |
| Premium private experience | Gobroad | Private-sector service model |
Section 5 — How CMCS Coordinates Access to Both Institutions
CMCS works with international patients seeking care at both Gobroad and FUSCC. Our coordination role differs slightly depending on the institution:
Coordinating with Gobroad
For patients choosing Gobroad, CMCS can assist with appointment scheduling, insurance pre-authorization support, medical record preparation, and on-site accompaniment. While Gobroad's own international patient team handles much of the in-hospital coordination, CMCS provides an independent patient advocate who works in your interest throughout the process.
Coordinating with FUSCC
For patients choosing FUSCC, CMCS provides end-to-end coordination: translating and preparing your medical records in the format required by FUSCC, identifying and securing an appointment with the most appropriate specialist, facilitating MDT case review where relevant, providing professional medical interpretation throughout all consultations and procedures, and managing post-treatment communication between your FUSCC specialist and your home-country medical team.
Remote Pre-Consultation at Both Institutions
For both Gobroad and FUSCC, CMCS can arrange a remote written or video pre-consultation before you commit to traveling to Shanghai. This allows you to receive a specialist's assessment of your case and make an informed decision about whether and where to proceed.
→ For a full overview of Shanghai's oncology landscape and top specialists, see: World’s Top Cancer Hospitals & Shanghai’s Oncology Leaders: A 2026 Guide.
→ For information on China-exclusive cancer therapies available at Shanghai institutions, see: China-Exclusive Cancer Therapies in 2026: Savolitinib, CAR-NKT & Beyond.
→ For a broader comparison of medical destinations across Asia and Europe, see: Choosing the Right Country for Medical Care in 2026.
Start with a Conversation
If you are trying to decide between Gobroad and FUSCC — or simply want an expert assessment of which Shanghai institution is best suited to your specific diagnosis — CMCS is here to help. We will review your case, explain your options clearly, and coordinate whichever pathway you choose.
Contact us to begin.
📧 contract@medicalsh.com
💬 WhatsApp: https://wa.me/message/3AM6KAGCW2BAD1
🌐 www.medicalsh.com
CMCS — China Medical Concierge Shanghai. Independent coordination for international patients seeking oncology care in Shanghai.
0 則留言